这是一篇来自已证抗体库的有关
人类 BST2的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合BST2 抗体。
BST2 同义词: CD317; TETHERIN; bone marrow stromal antigen 2; BST-2; HM1.24 antigen; NPC-A-7
BioLegend
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, 348405)被用于被用于流式细胞仪在人类样本上 (图 1s2). elife (2019) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(Biolegend, 348410)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1d). elife (2019) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, RS38E)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS Pathog (2018) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, 348410)被用于被用于流式细胞仪在人类样本上 (图 4b). J Virol (2018) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, RS38E)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 1c). J Cell Sci (2017) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(Biolegend, 348410)被用于. Sci Rep (2017) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(Biolegend, RS38E)被用于被用于流式细胞仪在人类样本上 (图 8c). PLoS Pathog (2017) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, 348410)被用于被用于流式细胞仪在人类样本上 (图 2). Traffic (2016) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegen d, 348404)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, 348410)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 3). PLoS ONE (2015) ncbi |
小鼠 单克隆(RS38E) | | BioLegend BST2抗体(BioLegend, 348406)被用于被用于流式细胞仪在人类样本上 (图 s4). Stem Cell Reports (2015) ncbi |
赛默飞世尔
小鼠 单克隆(26F8) | | 赛默飞世尔 BST2抗体(eBioscience, 16-3179-82)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5b). J Virol (2018) ncbi |
小鼠 单克隆(26F8) | | 赛默飞世尔 BST2抗体(eBiosciences, 26F8)被用于被用于免疫细胞化学在人类样本上 (图 6). PLoS Pathog (2015) ncbi |
小鼠 单克隆(26F8) | | 赛默飞世尔 BST2抗体(eBiosciences, 26F8)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s4). Nat Commun (2015) ncbi |
小鼠 单克隆(26F8) | | 赛默飞世尔 BST2抗体(eBioscience, 12-3179)被用于被用于流式细胞仪在人类样本上 (图 s4). Stem Cell Reports (2015) ncbi |
小鼠 单克隆(26F8) | | 赛默飞世尔 BST2抗体(eBioscience, 12-3179)被用于被用于流式细胞仪在人类样本上 (图 1). Virology (2015) ncbi |
亚诺法生技股份有限公司
小鼠 单克隆(2E6) | | 亚诺法生技股份有限公司 BST2抗体(Abnova, 2E6)被用于被用于免疫细胞化学在人类样本上浓度为1:750 (图 5a). J Cell Sci (2017) ncbi |
小鼠 多克隆 | | 亚诺法生技股份有限公司 BST2抗体(Abnova, B02P)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 3). elife (2016) ncbi |
小鼠 单克隆(2E6) | | 亚诺法生技股份有限公司 BST2抗体(Abnova, H00000684-M15)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 3). Virol J (2016) ncbi |
小鼠 多克隆 | | 亚诺法生技股份有限公司 BST2抗体(Abnova, H00000684-B02P)被用于被用于免疫印迹在人类免疫缺陷病毒1样本上 (图 2b). Cell Host Microbe (2016) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(E-4) | | 圣克鲁斯生物技术 BST2抗体(SantaCruz, sc-390719)被用于被用于免疫印迹在人类样本上 (图 1c). Cell (2018) ncbi |
艾博抗(上海)贸易有限公司
兔 多克隆 | | 艾博抗(上海)贸易有限公司 BST2抗体(Abcam, ab14694)被用于被用于免疫印迹在人类样本上 (图 3h). J Mol Biol (2018) ncbi |
Naamati A, Williamson J, Greenwood E, Marelli S, Lehner P, Matheson N. Functional proteomic atlas of HIV infection in primary human CD4+ T cells. elife. 2019;8:
pubmed 出版商
Langer S, Hammer C, Hopfensperger K, Klein L, Hotter D, De Jesus P,
et al. HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses. elife. 2019;8:
pubmed 出版商
Sithole N, Williams C, Vaughan A, Kenyon J, Lever A. DDX17 Specifically, and Independently of DDX5, Controls Use of the HIV A4/5 Splice Acceptor Cluster and Is Essential for Efficient Replication of HIV. J Mol Biol. 2018;430:3111-3128
pubmed 出版商
Urata S, Kenyon E, Nayak D, Cubitt B, Kurosaki Y, Yasuda J,
et al. BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection. PLoS Pathog. 2018;14:e1007172
pubmed 出版商
Heusinger E, Deppe K, Sette P, Krapp C, Kmiec D, Kluge S,
et al. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2. J Virol. 2018;92:
pubmed 出版商
Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H,
et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25
pubmed 出版商
Roy N, Pacini G, Berlioz Torrent C, Janvier K. Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2. J Cell Sci. 2017;130:1596-1611
pubmed 出版商
Romani B, Kavyanifard A, Allahbakhshi E. Functional conservation and coherence of HIV-1 subtype A Vpu alleles. Sci Rep. 2017;7:44894
pubmed 出版商
Yoder A, Guo K, Dillon S, Phang T, Lee E, Harper M,
et al. The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria. PLoS Pathog. 2017;13:e1006226
pubmed 出版商
Edgar J, Manna P, Nishimura S, Banting G, Robinson M. Tetherin is an exosomal tether. elife. 2016;5:
pubmed 出版商
Liu Y, Li M, Zhang D, Zhang M, Hu Q. HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway. Virol J. 2016;13:154
pubmed 出版商
Rapiteanu R, Davis L, Williamson J, Timms R, Paul Luzio J, Lehner P. A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic. 2016;17:940-58
pubmed 出版商
Krapp C, Hotter D, Gawanbacht A, McLaren P, Kluge S, Stürzel C,
et al. Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity. Cell Host Microbe. 2016;19:504-14
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Langer S, Hopfensperger K, Iyer S, Kreider E, Learn G, Lee L,
et al. A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. PLoS ONE. 2015;10:e0142118
pubmed 出版商
Bego M, Côté Ã, Aschman N, Mercier J, Weissenhorn W, Cohen Ã. Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells. PLoS Pathog. 2015;11:e1005024
pubmed 出版商
Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M,
et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562
pubmed 出版商
James S, Fox J, Afsari F, Lee J, Clough S, Knight C,
et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15
pubmed 出版商
Liu Y, Luo S, He S, Zhang M, Wang P, Li C,
et al. Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins. Virology. 2015;475:96-109
pubmed 出版商